A clinical trial protocol outlines the study design and objectives, mapping out assessments and operational details to support participant safety, site execution, and ultimately, the validity of your data. A…
Med Communications has benefited from the extensive skills, knowledge, and insights of Business Development Lead Stacy Witham, PharmD, for over a decade. Stacy received her Doctorate of Pharmacy (PharmD) from Lipscomb…
Scientific, medical, and patient advocacy conferences and meetings represent critical opportunities and inflection points for life science companies throughout the year during all phases of development and the product lifecycle….
As a veteran-founded business, Med Communications is aware of the importance of the Memorial Day holiday. As we prepare for the long holiday weekend in the US, let’s not forget…
The FDA, through the Center for Drug Evaluation and Research (CDER), imposes strict regulations on the pharmaceutical industry for every aspect of drug development and marketing for products in the…
Aggregate reports provide periodic review of safety data in a global and cumulative way. The process requires the collection and assessment of safety data as well as handling the necessary…
We’re excited to join @ISMPP at hashtag#ISMPPAnnual in DC! Together with key industry professionals, Med Communications staff members Stacy Witham and Tiago Silva are exploring how the intersection of diversity…
One of Med Communications’ regulatory writing experts helped a client refine and improve the usability of an Investigator’s Brochure (IB). The client set a challenging goal for their next annual…
In recognition of the important contributions made by nurses in the United States and around the world, we celebrate Nurses Week, May 6-12. The theme of this year’s celebration is…
Med Communications’ Scientific Communications staff applied a dedicated work model to provide seamless support for the MI initiatives of a large global pharmaceutical company. A top 10 pharmaceutical manufacturer with…
